For a growing biotech, the cost of lab space goes far beyond rent. From utilities, taxes, and CAM fees to lab equipment, service contracts, operational staff, regulatory compliance, and ongoing maintenance, the cost of running a lab adds up quickly.

‍

Labshares CEO Philip Borden recently joined MassBio's Jason Cordeiro on R&D Reimagined to break down the true cost of running a lab, biotech’s “Cathedral Problem”, and why the traditional incubator-to-lease path doesn’t work for many biotechs today. They also explore how shared labs like Labshares give biotech companies access to the space, equipment, infrastructure, and operational support they need without taking on the full cost and complexity themselves.

‍

Watch the clip below to hear Philip’s perspective on a more flexible approach to scaling a biotech company.

‍